Probiotic disruption of quorum sensing reduces virulence and increases cefoxitin sensitivity in methicillin-resistant Staphylococcus aureus.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
16 03 2023
16 03 2023
Historique:
received:
09
11
2022
accepted:
13
03
2023
entrez:
17
3
2023
pubmed:
18
3
2023
medline:
22
3
2023
Statut:
epublish
Résumé
Therapies which target quorum sensing (QS) systems that regulate virulence in methicillin-resistant Staphylococcus aureus (MRSA) are a promising alternative to antibiotics. QS systems play a crucial in the regulation of MRSA antibiotic resistance, exotoxin production, antioxidant protection and immune cell evasion, and are therefore attractive therapeutic targets to reduce the virulence of a pathogen. In the present work the the effects of bioactive peptides isolated from two strains of lactic acid bacteria were tested against antibiotic resistance, carotenoid production, resistance to oxidative killing and biofilm structure in two clinical MRSA isolates. The results obtained from fractional-inhibitory concentration assays with bulk and semi-purified bioactive molecules showed a significant synergistic effect increasing cefoxitin mediated killing of MRSA. This was coupled to a six-fold decrease of the major membrane pigment staphyloxanthin, and a 99% increase in susceptibility to oxidative stress mediated killing. Real-time quantitative PCR analysis of the QS-genes agrA and luxS, showed differential expression between MRSA strains, and a significant downregulation of the hemolysin gene hla. Light microscopy and scanning electron microscopy revealed alteration in biofilm formation and clustering behavior. These results demonstrate that bioactive metabolites may be effectively applied in tandem with beta-lactam antibiotics to sensitize MRSA to cefoxitin. Moreover, these results shown that several key QS-controlled virulence mechanisms are diminished by probiotic metabolites.
Identifiants
pubmed: 36928453
doi: 10.1038/s41598-023-31474-2
pii: 10.1038/s41598-023-31474-2
pmc: PMC10020441
doi:
Substances chimiques
Cefoxitin
6OEV9DX57Y
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4373Informations de copyright
© 2023. The Author(s).
Références
Clin Microbiol Infect. 2000 Sep;6(9):503-8
pubmed: 11168186
Sci Rep. 2018 Oct 1;8(1):14578
pubmed: 30275455
J Bacteriol. 1996 Oct;178(20):6036-42
pubmed: 8830703
Nat Rev Microbiol. 2019 Mar;17(3):141-155
pubmed: 30683887
J Biotechnol. 2015 May 10;201:2-14
pubmed: 25220028
PLoS One. 2014 Jul 17;9(7):e98634
pubmed: 25033196
Infect Immun. 1991 Dec;59(12):4332-7
pubmed: 1937793
FEMS Microbiol Lett. 2004 Dec 15;241(2):135-41
pubmed: 15598524
Front Microbiol. 2015 Oct 27;6:1174
pubmed: 26579084
Annu Rev Genet. 2009;43:197-222
pubmed: 19686078
Lancet. 2016 Jan 9;387(10014):176-87
pubmed: 26603922
Int J Med Microbiol. 2006 Apr;296(2-3):133-9
pubmed: 16487744
Infect Immun. 2011 May;79(5):1927-35
pubmed: 21402769
J Bacteriol. 2004 Jul;186(13):4085-99
pubmed: 15205410
Antimicrob Agents Chemother. 2011 Feb;55(2):526-31
pubmed: 21115796
Nat Chem Biol. 2011 Jun;7(6):348-50
pubmed: 21516114
Peptides. 2014 May;55:17-22
pubmed: 24531033
J Clin Invest. 2003 Dec;112(11):1620-5
pubmed: 14660735
J Bacteriol. 2005 Mar;187(5):1799-814
pubmed: 15716452
J Bacteriol. 2005 Dec;187(23):8181-4
pubmed: 16291691
Front Pharmacol. 2018 Mar 07;9:203
pubmed: 29563876
Front Microbiol. 2016 Sep 22;7:1460
pubmed: 27713728
Appl Environ Microbiol. 2009 Feb;75(4):1165-72
pubmed: 19088323
PLoS One. 2016 Jul 21;11(7):e0159768
pubmed: 27441894
Cell Host Microbe. 2015 Nov 11;18(5):604-12
pubmed: 26567511
Mol Cell. 2008 Oct 10;32(1):150-8
pubmed: 18851841
Front Microbiol. 2020 May 21;11:1028
pubmed: 32508801
Nature. 2018 Oct;562(7728):532-537
pubmed: 30305736
Trends Microbiol. 2016 Nov;24(11):862-871
pubmed: 27430191
Adv Sci (Weinh). 2019 Mar 30;6(11):1900030
pubmed: 31179216
Annu Rev Microbiol. 2010;64:143-62
pubmed: 20825344
J Bacteriol. 2001 Mar;183(6):1843-52
pubmed: 11222581
J Food Prot. 2010 Mar;73(3):452-60
pubmed: 20202329
Nat Rev Microbiol. 2019 Apr;17(4):203-218
pubmed: 30737488
Int J Food Microbiol. 2009 Apr 30;131(1):30-9
pubmed: 18687499
Antimicrob Agents Chemother. 2000 Feb;44(2):231-8
pubmed: 10639342
Int J Food Microbiol. 2012 Jun 1;156(3):255-63
pubmed: 22541391
J Electron Microsc (Tokyo). 2003;52(4):429-33
pubmed: 14599106
Proc Natl Acad Sci U S A. 2012 Jun 5;109(23):9095-100
pubmed: 22586129
J Exp Med. 2005 Jul 18;202(2):209-15
pubmed: 16009720
Antimicrob Agents Chemother. 2015 Mar;59(3):1512-8
pubmed: 25534736
Nat Microbiol. 2019 Jul;4(7):1114-1119
pubmed: 30936487